Related references
Note: Only part of the references are listed.A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2α
Sascha Seidel et al.
BRAIN (2010)
HIPK2-A therapeutical target to be (re)activated for tumor suppression Role in p53 activation and HIF-1α inhibition
Lavinia Nardinocchi et al.
CELL CYCLE (2010)
Practical strategies for suppressing hypoxia-inducible factor activity in cancer therapy
Mark F. McCarty et al.
MEDICAL HYPOTHESES (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
Transcriptional regulation of hypoxia-inducible factor 1α by HIPK2 suggests a novel mechanism to restrain tumor growth
Lavinia Nardinocchi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2009)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer
Simona Nanni et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Inhibition of HIF-Ialpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis
Lavinia Nardinocchi et al.
MOLECULAR CANCER (2009)
An inducible autoregulatory loop between HIPK2 and Siah2 at the apex of the hypoxic response
Marco A. Calzado et al.
NATURE CELL BIOLOGY (2009)
Targeting Hypoxia in Cancer Cells by Restoring Homeodomain Interacting Protein-Kinase 2 and p53 Activity and Suppressing HIF-1α
Lavinia Nardinocchi et al.
PLOS ONE (2009)
Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown
Rosa Puca et al.
CANCER RESEARCH (2008)
The role of hypoxia-inducible factors in tumorigenesis
E. B. Rankin et al.
CELL DEATH AND DIFFERENTIATION (2008)
Estrogen receptor-α and endothelial nitric oxide synthase nuclear complex regulates transcription of human telomerase
Annalisa Grasselli et al.
CIRCULATION RESEARCH (2008)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
HIF-dependent antitumorigenic effect of antioxidants in vivo
Ping Gao et al.
CANCER CELL (2007)
Mechanism of vascular endothelial growth factor expression mediated by cisplatin in human ovarian cancer cells
Xiao-Song Zhong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
RACK1 competes with HSP90 for binding to HIF-1α and is required for O2-independent and HSP90 inhibitor-induced degradation of HIF-1α
Ye V. Liu et al.
MOLECULAR CELL (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Clioquinol, a Cu(II)/Zn(II) chelator, inhibits both ubiquitination and asparagine hydroxylation of hypoxia-inducible factor-1α, leading to expression of vascular endothelial growth factor and erythropoietin in normoxic cells
Su Mi Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma:: HIF-2α promotes an aggressive phenotype
Linda Holmquist-Mengelbier et al.
CANCER CELL (2006)
Regulation of angiogenesis by hypoxia-inducible factor 1
Kiichi Hirota et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Epithelial-restricted gene profile of primary cultures from human prostate tumors: A molecular approach to predict clinical behavior of prostate cancer
S Nanni et al.
MOLECULAR CANCER RESEARCH (2006)
Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity:: Assessment of an oral agent that stimulates erythropoietin production
M Safran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations
V Di Stefana et al.
FEBS LETTERS (2005)
Evaluating hypoxia-inducible factor-1α as a cancer therapeutic target via inducible RNA interference in vivo
LM Li et al.
CANCER RESEARCH (2005)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation
CJ Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
K Kondo et al.
CANCER CELL (2002)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
Gene transfer of antisense hypoxia inducible factor-1 α enhances the therapeutic efficacy of cancer immunotherapy
X Sun et al.
GENE THERAPY (2001)
Suppression of tumor growth through disruption of hypoxia-inducible transcription
AL Kung et al.
NATURE MEDICINE (2000)
Share Paper
